Clinical Trial Update: Efficacy Study of EVT 201 to Treat Insomnia [Phase 2]

View source ↗

Summary

Phase 2 efficacy study of EVT 201 for insomnia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• EVT 201

Snippet

Sponsor: Evotec Neurosciences GmbH | Conditions: Sleep Initiation and Maintenance Disorders | Phase 2 | Status: COMPLETED